Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to discovering and developing differentiated small molecule therapeutics that target fundamental biological pathways of cancer. They leverage their proprietary Integrated Discovery Engine to build a broad pipeline of potentially first-in-class and/or best-in-class product candidates. Their lead product candidate, azenosertib (ZN-c3), is a WEE1 inhibitor being developed for various oncologic indications. The company is focused on addressing unmet medical needs in oncology with innovative treatments.
The New York headquarters serves as the central hub for Zentalis's corporate leadership, strategic planning, business development, investor relations, and administrative functions.
Located in a prominent Manhattan office building, the headquarters likely features modern office amenities and collaborative workspaces designed to support its corporate operations.
The work culture at Zentalis, particularly at its corporate headquarters, is expected to be dynamic, results-oriented, and collaborative, reflecting the fast-paced nature of the biopharmaceutical industry and its mission-driven focus on cancer therapeutics.
The New York City location provides Zentalis with direct access to global financial markets, a rich pool of business talent, and proximity to key partners and stakeholders in the pharmaceutical industry.
Zentalis Pharmaceuticals primarily operates from its key locations in the United States but has a global reach through its clinical development programs. The company conducts clinical trials for its novel cancer therapeutics in multiple regions, including North America, Europe, and Asia-Pacific. This global approach is essential for patient recruitment, regulatory engagement, and advancing their pipeline towards potential worldwide commercialization.
1350 Avenue of the Americas, Suite 2102
New York
NY
USA
Address: 10578 Science Center Drive, Suite 150, San Diego, CA 92121, USA
San Diego is a leading global biotechnology hub, providing Zentalis with access to a highly skilled scientific workforce, cutting-edge research institutions, and a vibrant ecosystem for collaboration and innovation in life sciences.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Zentalis Pharmaceuticals' leadership includes:
Zentalis Pharmaceuticals has been backed by several prominent investors over the years, including:
Over the past 12 months, Zentalis Pharmaceuticals has strengthened its executive team with key appointments, including a new Chief Business Officer and a new Chief Medical Officer, while also seeing a strategic transition for its former CMO.
Discover the tools Zentalis Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Zentalis Pharmaceuticals commonly uses the email format combining the first initial of the employee's first name with their full last name, followed by '@zentalis.com'. This is a frequent pattern in many corporations, particularly in the tech and pharmaceutical sectors.
[first_initial][last]@zentalis.com
Format
kblackwell@zentalis.com
Example
85%
Success rate
Zentalis Pharmaceuticals • May 9, 2024
Zentalis Pharmaceuticals reported its financial results for the first quarter of 2024 and provided updates on its clinical programs, including progress on azenosertib (ZN-c3) and other pipeline candidates, outlining key upcoming milestones....more
Zentalis Pharmaceuticals • March 21, 2024
The company announced the appointment of Kyle Rasbach, Pharm.D., as its new Chief Business Officer. His extensive experience in biopharmaceutical business development and strategy is expected to contribute significantly to Zentalis's growth....more
Zentalis Pharmaceuticals • June 3, 2024
Zentalis announced its participation and presentation at the Jefferies Healthcare Conference, where it would provide a corporate update and discuss its ongoing development programs with the investment community....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Zentalis Pharmaceuticals, are just a search away.